Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Both immature and mature fat cells are important for hair growth cycles, with immature cells promoting growth and mature cells possibly inhibiting it.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Adult stem cells are important for tissue repair and have therapeutic potential, but more research is needed to fully use them.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.